Hub : Traits :

Ulcerative Colitis

218 significantly associated models · 82 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	1781220	3219950	7	1	7.9e-10	8.0e-10	0.02180	86	RP3-395M20.9
2	1	7314655	8738937	2	1	3.2e-08	2.3e-09	0.01850	84	PARK7
3	1	19515061	21114833	2	3	1.5e-23	4.9e-31	0.85300	100	OTUD3 PLA2G5
4	1	160642451	162039394	3	2	2.7e-17	3.8e-17	0.01130	91	FCGR2A RP11-122G18.5
5	2	60466491	62087165	3	1	8.9e-11	1.8e-12	0.00527	84	PEX13
6	2	199443880	201021954	1	1	2.6e-07	2.3e-07	1.00000	100	SATB2
7	2	218382236	219846749	4	1	1.0e-08	2.0e-07	0.20800	94	AAMP
8	3	47911521	50932324	25	1	2.6e-14	2.3e-15	1.00000	100	FAM212A
9	4	122842267	123530993	1	1	1.2e-07	3.1e-06	0.00931	69	KIAA1109
10	5	131008194	132425049	1	1	1.6e-07	4.9e-06	0.28100	94	SLC22A5
11	5	158501850	159005439	1	1	2.3e-08	1.1e-09	0.01420	84	IL12B
12	6	116091635	117481404	1	1	2.0e-07	6.2e-07	0.16100	92	FAM26F
13	7	2032803	3510741	1	1	1.1e-08	1.2e-08	0.31500	97	AMZ1
14	7	5726022	7141565	1	1	2.0e-07	2.3e-05	0.82200	100	RAC1
15	7	106847492	108340749	3	1	9.9e-16	1.7e-15	0.00924	89	DLD
16	7	127878155	129284182	1	1	3.4e-09	2.9e-07	0.47200	98	IRF5
17	9	138558883	140071683	6	2	7.1e-15	5.8e-13	0.14800	96	CARD9 INPP5E
18	17	37137299	39048774	8	1	1.9e-10	9.2e-12	0.00996	86	RAPGEFL1
19	20	61576647	62912463	6	1	2.8e-11	3.4e-08	0.53600	99	RTEL1
20	21	45398656	45902320	1	1	2.1e-08	7.1e-11	0.00027	69	ICOSLG
21	22	49656585	51055900	1	1	1.6e-07	2.4e-08	1.00000	100	PIM3

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder or Schizophrenia	1.41	1	0	0.0	0.00	1.0e+00	RP3-395M20.9
Depressed Affect (Nagel 2018)	1.65	1	1	2.2	0.00	1.0e+00	FAM212A
Intelligence (Savage-Jansen 2018)	1.96	1	1	2.2	0.00	1.0e+00	FAM212A
Worry (Nagel 2018)	1.21	1	0	0.0	0.00	1.0e+00	SATB2
Crohns Disease (2017)	14.15	11	9	20.0	0.97	1.5e-06	CARD9 FAM212A ICOSLG IL12B INPP5E KIAA1109 PARK7 PEX13 RAPGEFL1 RTEL1 SLC22A5
Irritable Bowel Disease (IBD)	24.25	22	17	37.8	0.95	1.1e-11	AAMP AMZ1 CARD9 DLD FAM212A FCGR2A ICOSLG IL12B INPP5E KIAA1109 OTUD3 PARK7 PEX13 PIM3 PLA2G5 RAC1 RAPGEFL1 RP11-122G18.5 RP3-395M20.9 RTEL1 SATB2 SLC22A5
Ulcerative Colitis (UC)	26.23	24	18	40.0	0.99	3.7e-20	AAMP AMZ1 CARD9 DLD FAM212A FAM26F FCGR2A ICOSLG IL12B INPP5E IRF5 KIAA1109 OTUD3 PARK7 PEX13 PIM3 PLA2G5 RAC1 RAPGEFL1 RP11-122G18.5 RP3-395M20.9 RTEL1 SATB2 SLC22A5
Verbal and Numeric Reasoning (VNR)	1.74	1	1	2.2	0.00	1.0e+00	FAM212A
Breast Cancer	1.43	3	0	0.0	0.00	1.0e+00	FAM212A PARK7 SLC22A5
Prostate Cancer	2.24	2	0	0.0	0.00	1.0e+00	FAM212A RTEL1
Age at First Birth	1.97	1	1	2.2	0.00	1.0e+00	FAM212A
Body Mass Index (BMI) (2010)	1.46	1	0	0.0	0.00	1.0e+00	RP3-395M20.9
Crohns Disease (2012)	10.15	7	7	15.6	0.97	2.3e-04	FAM212A ICOSLG IL12B PEX13 RAPGEFL1 RTEL1 SLC22A5
HDL Cholesterol	1.74	2	1	2.2	0.00	1.0e+00	RAC1 RAPGEFL1
LDL Cholesterol	0.96	1	0	0.0	0.00	1.0e+00	FCGR2A
Lupus	4.07	2	2	4.4	0.00	1.0e+00	FCGR2A IRF5
Primary Biliary Cirrhosis	2.85	2	1	2.2	0.00	1.0e+00	IRF5 RAPGEFL1
Rheumatoid Arthritis	2.68	1	0	0.0	0.00	1.0e+00	FCGR2A
Schizophrenia (2014)	1.14	1	0	0.0	0.00	1.0e+00	FCGR2A
Blood Eosinophil Count	4.45	5	4	8.9	-0.29	6.4e-01	AMZ1 IRF5 KIAA1109 RP3-395M20.9 SLC22A5
Blood Platelet Count	1.72	7	5	11.1	-0.52	2.3e-01	AAMP AMZ1 IRF5 PARK7 RP11-122G18.5 RTEL1 SLC22A5
Blood Red Count	0.59	2	1	2.2	0.00	1.0e+00	FCGR2A RTEL1
Blood White Count	10.68	9	8	17.8	-0.43	2.5e-01	AAMP AMZ1 CARD9 FAM212A INPP5E PEX13 RAPGEFL1 RTEL1 SLC22A5
Heel T-Score	1.00	6	2	4.4	-0.41	4.2e-01	AAMP AMZ1 FAM212A IRF5 RAC1 SATB2
BMI	1.56	3	1	2.2	0.00	1.0e+00	FAM212A RP3-395M20.9 RTEL1
Height	3.41	9	8	17.8	0.45	2.3e-01	AAMP AMZ1 CARD9 FAM212A FAM26F INPP5E IRF5 PARK7 SLC22A5
Waist Hip Ratio (WHR)	0.84	2	1	2.2	0.00	1.0e+00	AAMP DLD
Systolic Blood Pressure	0.92	3	1	2.2	0.00	1.0e+00	AAMP FAM212A RAC1
Smoking Status	1.47	1	1	2.2	0.00	1.0e+00	RTEL1
Allergy or Eczema	6.04	6	4	8.9	0.43	3.9e-01	AMZ1 KIAA1109 PEX13 RAPGEFL1 RTEL1 SLC22A5
Cardiovascular Disease	1.30	1	0	0.0	0.00	1.0e+00	SLC22A5
Hypothyroidism (self reported)	1.47	2	0	0.0	0.00	1.0e+00	KIAA1109 PEX13
Respiratory disease	8.10	4	3	6.7	-0.66	3.4e-01	KIAA1109 RAPGEFL1 RTEL1 SLC22A5
Lung FEV1/FVC ratio	1.90	4	3	6.7	0.44	5.6e-01	AMZ1 FAM212A RAPGEFL1 SLC22A5
Lung FVC	2.21	7	5	11.1	-0.15	7.6e-01	AAMP CARD9 FAM212A PARK7 RTEL1 SATB2 SLC22A5
Neuroticism	1.21	2	0	0.0	0.00	1.0e+00	FAM212A SATB2
Chronotype (morning person)	1.80	2	0	0.0	0.00	1.0e+00	KIAA1109 PARK7
Tanning	0.13	1	0	0.0	0.00	1.0e+00	PIM3
Hand grip strength (left)	1.70	3	0	0.0	0.00	1.0e+00	AMZ1 FCGR2A SLC22A5
Number of treatments/medications taken	2.16	1	1	2.2	0.00	1.0e+00	FAM212A
Average weekly spirits intake	1.82	1	0	0.0	0.00	1.0e+00	FAM212A
Hearing difficulty/problems: Yes	1.40	1	0	0.0	0.00	1.0e+00	SATB2
Relative age of first facial hair	1.22	1	0	0.0	0.00	1.0e+00	SATB2
Systolic blood pressure, automated reading	0.92	1	0	0.0	0.00	1.0e+00	FAM212A
Medication: Co-codamol	1.78	1	0	0.0	0.00	1.0e+00	FAM212A
Diabetes (father)	1.51	1	0	0.0	0.00	1.0e+00	PIM3
Impedance of leg (right)	0.63	1	0	0.0	0.00	1.0e+00	RP11-122G18.5
Leg fat-free mass (left)	2.37	4	2	4.4	0.95	4.8e-02	AAMP AMZ1 FAM212A PARK7
Trunk fat percentage	1.88	4	2	4.4	0.48	5.2e-01	AMZ1 FAM212A RP3-395M20.9 RTEL1
Hand grip strength (right)	1.70	2	0	0.0	0.00	1.0e+00	FCGR2A SLC22A5
Current tobacco smoking	1.70	1	1	2.2	0.00	1.0e+00	RTEL1
Fed-up feelings	1.73	1	1	2.2	0.00	1.0e+00	FAM212A
Relative age voice broke	1.21	1	0	0.0	0.00	1.0e+00	SATB2
Taking other prescription medications	2.95	2	1	2.2	0.00	1.0e+00	FAM212A RAPGEFL1
Age when periods started (menarche)	2.90	3	1	2.2	0.00	1.0e+00	FAM212A IRF5 SATB2
High blood pressure	0.88	1	0	0.0	0.00	1.0e+00	SLC22A5
Hayfever, allergic rhinitis or eczema	6.10	5	4	8.9	0.27	6.6e-01	KIAA1109 PEX13 RAPGEFL1 RTEL1 SLC22A5
Medication: Levothyroxine sodium	1.67	1	0	0.0	0.00	1.0e+00	PEX13
Sitting height	3.19	6	6	13.3	0.62	1.9e-01	AAMP AMZ1 CARD9 FAM26F INPP5E PARK7
Body mass index (BMI)	1.63	2	1	2.2	0.00	1.0e+00	FAM212A RTEL1
Leg predicted mass (left)	2.35	4	2	4.4	0.95	4.6e-02	AAMP AMZ1 FAM212A PARK7
Trunk fat mass	2.43	3	2	4.4	0.00	1.0e+00	AMZ1 FAM212A RTEL1
Waist circumference	1.82	3	2	4.4	0.00	1.0e+00	AMZ1 FAM212A RTEL1
Nervous feelings	1.03	1	0	0.0	0.00	1.0e+00	SATB2
Frequency of tenseness / restlessness in last 2 weeks	1.10	1	0	0.0	0.00	1.0e+00	FAM212A
Forced vital capacity (FVC)	1.93	5	3	6.7	0.46	4.4e-01	AAMP AMZ1 FAM212A RTEL1 SATB2
Qualifications: None of the above	1.65	1	1	2.2	0.00	1.0e+00	FAM212A
Allergy	7.29	6	4	8.9	-0.20	7.0e-01	AMZ1 KIAA1109 PEX13 RAPGEFL1 RTEL1 SLC22A5
Pain all over the body in last month	1.89	1	0	0.0	0.00	1.0e+00	FAM212A
Hayfever/allergic rhinitis (self-reported)	2.77	2	1	2.2	0.00	1.0e+00	KIAA1109 RAPGEFL1
Fluid intelligence score	1.74	1	1	2.2	0.00	1.0e+00	FAM212A
Weight	2.64	3	2	4.4	0.00	1.0e+00	AMZ1 FAM212A PARK7
Impedance of arm (right)	1.51	5	1	2.2	0.64	2.4e-01	AMZ1 FAM212A RAC1 RAPGEFL1 SATB2
Arm fat percentage (right)	1.41	3	1	2.2	0.00	1.0e+00	AMZ1 FAM212A RTEL1
Trunk fat-free mass	2.39	6	3	6.7	0.56	2.4e-01	AAMP AMZ1 CARD9 FAM212A INPP5E PARK7
Hip circumference	2.32	4	2	4.4	0.65	3.5e-01	AMZ1 FAM212A PARK7 RTEL1
Alcohol intake versus 10 years previously	1.80	1	1	2.2	0.00	1.0e+00	FAM212A
Father's age at death	1.64	1	0	0.0	0.00	1.0e+00	FAM212A
Worrier / anxious feelings	1.05	1	0	0.0	0.00	1.0e+00	SATB2
Forced expiratory volume in 1-second (FEV1)	1.65	3	2	4.4	0.00	1.0e+00	AAMP FAM212A RTEL1
Qualifications: A levels/AS levels or equivalent	2.54	1	1	2.2	0.00	1.0e+00	FAM212A
Mouth/teeth dental problems: Dentures	1.41	1	0	0.0	0.00	1.0e+00	FAM212A
Asthma	7.52	3	3	6.7	0.00	1.0e+00	KIAA1109 RAPGEFL1 SLC22A5
Forced expiratory volume in 1-second (FEV1), Best measure	1.68	4	1	2.2	0.59	4.1e-01	AAMP FAM212A ICOSLG SATB2
Impedance of arm (left)	1.64	5	1	2.2	0.66	2.3e-01	AMZ1 FAM212A RAC1 RAPGEFL1 SATB2
Arm fat mass (right)	1.91	3	2	4.4	0.00	1.0e+00	AMZ1 FAM212A RTEL1
Trunk predicted mass	2.36	6	3	6.7	0.56	2.5e-01	AAMP AMZ1 CARD9 FAM212A INPP5E PARK7
Standing height	3.38	8	6	13.3	0.44	2.8e-01	AAMP AMZ1 CARD9 FAM26F INPP5E IRF5 PARK7 SLC22A5
Birth weight of first child	1.48	1	0	0.0	0.00	1.0e+00	RAC1
Qualifications: O levels/GCSEs or equivalent	1.57	1	0	0.0	0.00	1.0e+00	FAM212A
Medication: Paracetamol	1.19	1	0	0.0	0.00	1.0e+00	FAM212A
Hypothyroidism/myxoedema (self-reported)	1.56	1	0	0.0	0.00	1.0e+00	KIAA1109
Medication: Ventolin 100micrograms inhaler	4.05	2	2	4.4	0.00	1.0e+00	KIAA1109 RAPGEFL1
Birth weight	2.20	2	1	2.2	0.00	1.0e+00	AMZ1 PIM3
Forced vital capacity (FVC), Best measure	1.87	5	2	4.4	0.51	3.8e-01	AAMP AMZ1 FAM212A RTEL1 SATB2
Body fat percentage	1.81	4	2	4.4	0.28	7.2e-01	AMZ1 FAM212A RP3-395M20.9 RTEL1
Leg fat percentage (right)	1.93	3	2	4.4	0.00	1.0e+00	FAM212A RP3-395M20.9 RTEL1
Arm fat-free mass (right)	2.35	5	3	6.7	0.39	5.2e-01	AAMP AMZ1 CARD9 FAM212A PARK7
Worry too long after embarrassment	1.27	1	0	0.0	0.00	1.0e+00	PEX13
Wheeze or whistling in the chest in last year	4.30	4	4	8.9	-0.59	4.1e-01	FAM212A KIAA1109 RAPGEFL1 RTEL1
Age at first live birth	1.59	1	1	2.2	0.00	1.0e+00	FAM212A
Qualifications: College or University degree	2.83	3	1	2.2	0.00	1.0e+00	FAM212A PEX13 RTEL1
Emphysema/chronic bronchitis	2.14	1	0	0.0	0.00	1.0e+00	RAPGEFL1
Medication: Seretide 50 evohaler	2.63	2	0	0.0	0.00	1.0e+00	FAM212A KIAA1109
Whole body fat mass	2.35	3	2	4.4	0.00	1.0e+00	AMZ1 FAM212A RTEL1
Leg fat mass (right)	2.17	4	2	4.4	0.26	7.4e-01	AMZ1 FAM212A RP3-395M20.9 RTEL1
Arm predicted mass (right)	2.44	5	3	6.7	0.38	5.2e-01	AAMP AMZ1 CARD9 FAM212A PARK7
Pulse rate, automated reading	0.99	1	0	0.0	0.00	1.0e+00	FAM212A
Alcohol intake frequency.	0.86	1	0	0.0	0.00	1.0e+00	FAM212A
Comparative height size at age 10	2.76	5	3	6.7	0.71	1.8e-01	AAMP AMZ1 CARD9 INPP5E SLC22A5
Suffer from 'nerves'	1.54	1	1	2.2	0.00	1.0e+00	SATB2
Overall health rating	1.98	2	1	2.2	0.00	1.0e+00	AMZ1 FAM212A
Chest pain or discomfort	1.41	1	0	0.0	0.00	1.0e+00	RAPGEFL1
Age at last live birth	1.86	1	1	2.2	0.00	1.0e+00	FAM212A
Leg pain on walking	1.25	1	0	0.0	0.00	1.0e+00	FAM212A
Forced expiratory volume in 1-second (FEV1), predicted	2.26	2	1	2.2	0.00	1.0e+00	AMZ1 CARD9
Whole body fat-free mass	2.43	6	3	6.7	0.55	2.6e-01	AAMP AMZ1 CARD9 FAM212A INPP5E PARK7
Leg fat-free mass (right)	2.32	5	1	2.2	0.46	4.4e-01	AAMP AMZ1 CARD9 FAM212A PARK7
Arm fat percentage (left)	1.50	4	2	4.4	0.19	8.1e-01	AMZ1 FAM212A RP3-395M20.9 RTEL1
Mood swings	1.16	1	1	2.2	0.00	1.0e+00	FAM212A
Loneliness, isolation	1.21	1	0	0.0	0.00	1.0e+00	FAM212A
Qualifications: nursing, teaching	1.52	1	0	0.0	0.00	1.0e+00	FAM212A
Mouth/teeth dental problems: Mouth ulcers	2.44	3	1	2.2	0.00	1.0e+00	IL12B IRF5 RAPGEFL1
Asthma (self-reported)	7.57	3	3	6.7	0.00	1.0e+00	KIAA1109 RAPGEFL1 SLC22A5
Smoking status: Current	1.56	1	0	0.0	0.00	1.0e+00	RTEL1
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.59	2	0	0.0	0.00	1.0e+00	AMZ1 RAPGEFL1
Whole body water mass	2.39	6	3	6.7	0.55	2.6e-01	AAMP AMZ1 CARD9 FAM212A INPP5E PARK7
Leg predicted mass (right)	2.32	5	1	2.2	0.45	4.4e-01	AAMP AMZ1 CARD9 FAM212A PARK7
Arm fat mass (left)	1.91	3	2	4.4	0.00	1.0e+00	AMZ1 FAM212A RTEL1
Number of self-reported non-cancer illnesses	1.92	1	0	0.0	0.00	1.0e+00	RAPGEFL1
Miserableness	1.84	2	1	2.2	0.00	1.0e+00	FAM212A RAPGEFL1
Guilty feelings	1.23	1	0	0.0	0.00	1.0e+00	FAM212A
Financial situation satisfaction	1.05	1	0	0.0	0.00	1.0e+00	FAM212A
Medication: Paracetamol	1.26	1	0	0.0	0.00	1.0e+00	FAM212A
Basal metabolic rate	2.53	5	3	6.7	0.41	4.9e-01	AAMP AMZ1 CARD9 FAM212A PARK7
Leg fat percentage (left)	1.97	3	2	4.4	0.00	1.0e+00	FAM212A RP3-395M20.9 RTEL1
Arm fat-free mass (left)	2.37	6	3	6.7	0.49	3.3e-01	AAMP AMZ1 CARD9 FAM212A INPP5E PARK7
Number of operations (self-reported)	2.46	2	1	2.2	0.00	1.0e+00	AMZ1 PARK7
Average weekly beer plus cider intake	1.31	1	0	0.0	0.00	1.0e+00	FAM212A
Diastolic blood pressure, automated reading	1.47	2	1	2.2	0.00	1.0e+00	FAM212A RTEL1
Unable to work because of sickness or disability	0.93	1	0	0.0	0.00	1.0e+00	DLD
Vascular/heart problems diagnosed by doctor	1.07	1	0	0.0	0.00	1.0e+00	SLC22A5
Medication: Omeprazole (e.g. Zanprol)	1.51	1	0	0.0	0.00	1.0e+00	SATB2
Pain experienced in last month	1.48	1	0	0.0	0.00	1.0e+00	FAM212A
Impedance of whole body	0.99	2	1	2.2	0.00	1.0e+00	FAM212A SATB2
Leg fat mass (left)	2.23	4	2	4.4	0.25	7.5e-01	AMZ1 FAM212A RP3-395M20.9 RTEL1
Arm predicted mass (left)	2.45	6	3	6.7	0.48	3.4e-01	AAMP AMZ1 CARD9 FAM212A INPP5E PARK7

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	2	0.060	1.5
GTEx	Adipose Visceral Omentum	5	0.254	1.5
GTEx	Adrenal Gland	1	0.071	1.6
GTEx	Artery Aorta	2	0.070	1.5
GTEx	Artery Coronary	1	0.088	1.6
GTEx	Artery Tibial	5	0.139	1.5
GTEx	Brain Caudate basal ganglia	0	0.000	1.5
GTEx	Brain Cerebellar Hemisphere	4	0.277	1.6
GTEx	Brain Cerebellum	6	0.313	1.5
GTEx	Brain Cortex	1	0.100	1.6
GTEx	Brain Frontal Cortex BA9	2	0.223	1.5
GTEx	Brain Hippocampus	0	0.000	1.4
GTEx	Brain Hypothalamus	2	0.351	1.6
GTEx	Brain Nucleus accumbens basal ganglia	1	0.119	1.5
GTEx	Brain Putamen basal ganglia	0	0.000	1.4
GTEx	Breast Mammary Tissue	3	0.158	1.5
GTEx	Breast Mammary Tissue (Male)	1	0.088	1.4
GTEx	Breast Mammary Tissue (Female)	2	0.129	1.5
GTEx	Cells EBV-transformed lymphocytes	5	0.364	1.7
GTEx	Cells Transformed fibroblasts	6	0.148	1.5
GTEx	Colon Sigmoid	1	0.071	1.6
GTEx	Colon Transverse	3	0.151	1.6
GTEx	Esophagus Gastroesophageal Junction	0	0.000	1.5
GTEx	Esophagus Mucosa	4	0.125	1.6
GTEx	Esophagus Muscularis	7	0.225	1.5
GTEx	Heart Atrial Appendage	3	0.196	1.5
GTEx	Heart Left Ventricle	0	0.000	1.5
GTEx	Liver	0	0.000	1.5
GTEx	Lung	4	0.145	1.6
GTEx	Muscle Skeletal	2	0.072	1.5
GTEx	Nerve Tibial	6	0.144	1.5
GTEx	Ovary	1	0.114	1.6
GTEx	Pancreas	1	0.063	1.5
GTEx	Pituitary	0	0.000	1.6
GTEx	Prostate	1	0.124	1.6
GTEx	Skin Not Sun Exposed Suprapubic	3	0.126	1.5
GTEx	Skin Sun Exposed Lower leg	5	0.143	1.6
GTEx	Small Intestine Terminal Ileum	0	0.000	1.4
GTEx	Spleen	4	0.292	1.7
GTEx	Stomach	1	0.072	1.5
GTEx	Testis	6	0.196	1.5
GTEx	Thyroid	4	0.104	1.5
GTEx	Uterus	1	0.183	1.6
GTEx	Vagina	1	0.164	1.6
GTEx	Whole Blood	6	0.313	1.8
METSIM	Adipose	6	0.134	1.5
NTR	Blood	9	0.378	1.6
ROSMAP	Brain Pre-frontal Cortex	7	0.164	1.6
YFS	Blood	9	0.199	1.6
CommonMind	Brain Pre-frontal Cortex	6	0.114	1.5
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	2	0.129	1.5
The Cancer Genome Atlas	Breast Invasive Carcinoma	6	0.145	1.5
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Colon Adenocarcinoma	3	0.156	1.6
The Cancer Genome Atlas	Esophageal Carcinoma	1	0.155	1.4
The Cancer Genome Atlas	Glioblastoma Multiforme	1	0.105	1.5
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	4	0.156	1.6
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	1	0.026	1.4
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	4	0.208	1.5
The Cancer Genome Atlas	Brain Lower Grade Glioma	6	0.148	1.4
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	1	0.096	1.4
The Cancer Genome Atlas	Lung Adenocarcinoma	6	0.218	1.5
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	4	0.171	1.5
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	1	0.067	1.5
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	6	0.382	1.5
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	2	0.162	1.5
The Cancer Genome Atlas	Prostate Adenocarcinoma	6	0.138	1.5
The Cancer Genome Atlas	Rectum Adenocarcinoma	1	0.151	1.5
The Cancer Genome Atlas	Soft Tissue Sarcoma	1	0.101	1.5
The Cancer Genome Atlas	Skin Cutaneous Melanoma	0	0.000	1.5
The Cancer Genome Atlas	Stomach Adenocarcinoma	1	0.063	1.4
The Cancer Genome Atlas	Testicular Germ Cell Tumors	1	0.083	1.6
The Cancer Genome Atlas	Thyroid Carcinoma	9	0.186	1.5
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	1	0.211	1.6